ACL Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$210,880.00

Australian Clinical Labs Insider Trading History Chart

This chart shows the insider buying and selling history at Australian Clinical Labs by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Australian Clinical Labs Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/27/2021 01:22 PM ET

This chart shows the closing price history over time for ACL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Australian Clinical Labs Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/4/2022Michael StanfordInsiderSell20,000A$3.55A$71,000.00
9/15/2022Michael AlscherInsiderIssued24,574A$4.27A$104,930.98
9/9/2022Leanne RoweInsiderSell32,500A$4.30A$139,880.00
4/21/2022Andrew DuttonInsiderIssued1,897A$5.06A$9,598.82
11/22/2021Mark HaberlinInsiderBuy22,500A$4.40A$98,977.50
5/25/2021Melinda McGrathInsiderIssued247,252A$3.64A$899,997.28
See Full Table

SEC Filings (Institutional Ownership Changes) for Australian Clinical Labs (ASX:ACL)

Australian Clinical Labs logo
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Read More on Australian Clinical Labs

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

26.37%

Beta

N/A

Who are the company insiders with the largest holdings of Australian Clinical Labs?

Australian Clinical Labs' top insider shareholders include:
  1. Andrew Dutton (Insider)
  2. Leanne Rowe (Insider)
  3. Mark Haberlin (Insider)
  4. Melinda McGrath (Insider)
  5. Michael Alscher (Insider)
  6. Michael Stanford (Insider)
Learn More about top insider investors at Australian Clinical Labs.